TGFB1 and neoplasm: Thus, in breast (Richardsen et al., 2012), colorectal (Calon et al., 2012; Tsushima et al., 1996) and prostate cancers (Steiner and Barrack, 1992), elevated expression of TGF‐β in the tumour area is associated with poor prognosis and locally advanced disease.